Rocket, Labs

Rocket Lab's Post-Rally Test: $18M in Insider Sales and a $90M Space Force Win

04.06.2026 - 16:02:01 | boerse-global.de

Rocket Lab stock fell 7% after insiders sold $18M, but CFO gifted shares. Q1 revenue surged 63.5%, backlog hit $2.2B with $1.3B in defense contracts.

Rocket Lab Stock Drops 7% Amid Insider Selling, But Defense Contracts Fuel Growth
Rocket - Rocket Lab USA 04.06.2026 - Bild: über boerse-global.de

Rocket Lab rode a towering wave of enthusiasm through May, notching eight record highs in its best month since November 2024. But the tide turned abruptly this week. The stock shed roughly 7% on Wednesday to close at $114.70, after briefly touching as high as $151 during the rally. Nearly 21 million shares changed hands, close to the daily average of 24 million, signaling that profit-takers had arrived in force.

The selling pressure had a face. Four insiders collectively unloaded $18 million worth of stock, triggering the sharpest one-day sell-off in more than two years. Director Alexander R. Slusky led the exodus, selling 60,000 shares for about $9 million. President Marvin Bradford Clevenger disposed of 3,500 shares at an average price of $146.67, pocketing roughly $513,000. COO Frank Klein and Chief Legal Officer Arjun Kampani also reduced their holdings through pre-arranged trading plans.

The picture is more nuanced than a blanket insider exodus, however. CFO Adam Spice, rather than selling, transferred 188,172 shares as gifts at zero dollar per share on May 29 and June 1 — a move that doesn't add supply to the open market. He retains 920,325 shares directly and another 250,000 through a trust. The distinction matters as analysts parse the signals.

The sell-off unfolded against a backdrop of otherwise strong operational results. Rocket Lab posted record first-quarter revenue of $200.3 million, a 63.5% year-over-year surge. The GAAP gross margin held at 38.2%, while the net loss narrowed from $60.6 million to $45 million. The balance sheet remains well padded, with cash and short-term securities totaling roughly $1.38 billion as of March 31.

Should investors sell immediately? Or is it worth buying Rocket Lab USA?

Management's second-quarter guidance calls for revenue between $225 million and $240 million, with an adjusted EBITDA loss of $20 million to $26 million. The trajectory is improving, but profitability remains a work in progress.

A major catalyst arrived on May 21: the U.S. Space Force awarded Rocket Lab a $90 million contract to design, build and operate two geostationary satellites equipped with the Heimdall space surveillance system. It marks the company's first satellite program for geostationary orbit, underscoring its evolution from launch provider to full-scale defense and space infrastructure integrator.

That win builds on an even larger prize from the Space Development Agency. Rocket Lab's proposed solution for the Tracking Layer constellation passed its system requirements review and now serves as the technical foundation for the program. The resulting contract is worth $816 million, on top of an earlier $515 million deal, bringing total SDA-related awards to more than $1.3 billion.

The backlog has swollen accordingly. At May 7 it stood at roughly $2.2 billion, up 20% sequentially and 108% year-over-year. Rocket Lab also closed its acquisition of Motiv Space Systems, rebranded as Rocket Lab Robotics, whose technology has flown on NASA's Mars Perseverance rover and other planetary missions.

Rocket Lab USA at a turning point? This analysis reveals what investors need to know now.

Institutional investors remain split. Recent filings show 541 institutions increased their positions while 363 trimmed. The moves were large in both directions: Capital World Investors sold 8.96 million shares in the first quarter, a 55.3% cut, while Capital International Investors added 6.7 million shares over the same period.

Despite the pullback, the stock still trades well above its moving averages — the 50-day sits at $93.14 and the 200-day at $76.94 — reflecting how rapidly the market revalued the company. The share price is up 213% since September 2025. The question now is whether the next quarterly report can justify the premium. If Rocket Lab hits its $225 million-to-$240 million revenue target and keeps the Neutron rocket on schedule, the fundamental case stays intact. But any stumble — whether from further insider moves, cooling SpaceX-related sentiment, or cost overruns — could deepen the correction.

Ad

Rocket Lab USA Stock: New Analysis - 4 June

Fresh Rocket Lab USA information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.

Read our updated Rocket Lab USA analysis...

So schätzen die Börsenprofis Rocket Aktien ein!

<b>So schätzen die Börsenprofis Rocket Aktien ein!</b>
Seit 2005 liefert der Börsenbrief trading-notes verlässliche Anlage-Empfehlungen – dreimal pro Woche, direkt ins Postfach. 100% kostenlos. 100% Expertenwissen. Trage einfach deine E-Mail Adresse ein und verpasse ab heute keine Top-Chance mehr. Jetzt abonnieren.
Für. Immer. Kostenlos.
en | US7731221062 | ROCKET | boerse | 69483078 |